Where does Stichting Radboud universitair medisch centrum rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Stichting Radboud universitair medisch centrum ranks #30,261 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Stichting Radboud universitair medisch centrum hold?

Stichting Radboud universitair medisch centrum holds 9 US utility patents granted between 2021 and 2025, spanning 10 technology areas.

What is Stichting Radboud universitair medisch centrum's Innovation Score?

Stichting Radboud universitair medisch centrum has an Innovation Score of 48.9 out of 100 (top 16% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Stichting Radboud universitair medisch centrum's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Stichting Radboud universitair medisch centrum.

What does claim depth mean for Stichting Radboud universitair medisch centrum's patents?

Stichting Radboud universitair medisch centrum's patents average 16.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Stichting Radboud universitair medisch centrum

Q: What technology areas does Stichting Radboud universitair medisch centrum focus on?

Stichting Radboud universitair medisch centrum's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 4 patents, ranking #4,040 of 6,058 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Q: How is the Stichting Radboud universitair medisch centrum patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 9 granted patents across 10 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Stichting ranks #30,261 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 10 technology areas.

#30,261
of 49,997 US assignees by volume: Top 16%
by Innovation Score (48.9/100): 16.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R30261 · Foreign Corporation #30,261 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 9 grants
MID-PACK #30,261/49,997
PHOTO-FINISH Stealthbits
CPC-FOCUS A61P · 10 areas
INNOV-PAR 48.9/100
CLAIMS-RICH 16.3 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Stealthbits Technologies LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Stichting’s 48.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.0 pts (16%) Velocity 20.0 pts (41%) Breadth 11.2 pts (23%) Claim depth 9.8 pts (20%)

Qualcomm Incorporated · highest

85
Stichting Radboud… · this assignee

49
3D Lighting… · lowest

7

What this shows Stichting's Innovation Score is 48.9/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Stichting?

Each dot is one of Stichting’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Stichting’s own 16.3 claims/patent is at or below the 17.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Stichting vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Stichting's grants concentrate

Stichting Radboud universitair medisch centrum is a focused PatentsView assignee: 10 CPC subclasses with 44.4% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2021. By volume, Stichting sits between Stealthbits Technologies LLC and Stormtrap, LLC.

Stichting's three-year grant acceleration

Stichting Radboud universitair medisch centrum shows 7 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Stealthbits

9
Steel King Indust…

9
Stemline Therapeu…

9
Sterling Industry…

9
Stichting VU

9
Stopinc Aktienges…

9
Storage Engine

9
Stormtrap

9
Stichting Radboud… ◀

9

What this shows Stichting holds 9 patents at rank #30,252, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Stichting

By rank, the assignees closest to #30,252 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Stichting's primary technology class.

Stichting's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Stichting Radboud universitair medisch centrum patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	1	11.1%
2022	3	33.3%
2023	1	11.1%
2024	3	33.3%
2025partial year	1	11.1%

Which technologies does Stichting Radboud universitair medisch centrum patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

A61B - DIAGNOSIS; SURGERY; Identification 2

G06T - Image Data Processing OR Generation, IN General 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 1

C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients 1

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Stichting Radboud universitair medisch centrum's patent record in context - here's where to go next.

Stichting Radboud universitair medisch centrum's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 44.4% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #30,261 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Stichting Radboud universitair medisch centrum against Stealthbits Technologies LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.